SIMPLEX TRADING, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2021$7,000
-36.4%
94
-20.3%
0.00%
Q3 2021$11,0000.0%1180.0%0.00%
Q2 2021$11,000
-75.6%
118
-70.5%
0.00%
Q1 2021$45,000
-97.6%
400
-98.3%
0.00%
-100.0%
Q2 2020$1,844,000
+171.6%
23,579
+54.3%
0.00%
+200.0%
Q1 2020$679,000
+24.6%
15,285
+19.7%
0.00%0.0%
Q4 2019$545,000
+14.7%
12,772
+14.9%
0.00%0.0%
Q3 2019$475,000
+90.8%
11,113
+209.3%
0.00%0.0%
Q1 2019$249,000
+295.2%
3,593
+332.4%
0.00%
Q3 2018$63,000
-54.0%
831
-69.2%
0.00%
-100.0%
Q1 2018$137,000
+53.9%
2,696
+87.1%
0.01%
+50.0%
Q2 2017$89,000
-83.4%
1,441
-81.8%
0.00%
-82.6%
Q1 2017$535,000
+5.7%
7,898
+9.7%
0.02%
-23.3%
Q4 2016$506,000
+173.5%
7,198
+174.9%
0.03%
+130.8%
Q3 2016$185,000
+224.6%
2,618
+124.3%
0.01%
+225.0%
Q2 2016$57,0001,1670.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2016
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders